Open-label non-controlled study to examine the safety and efficacy of long-term administration of KRP-114V intended for overactive bladder patients

Trial Profile

Open-label non-controlled study to examine the safety and efficacy of long-term administration of KRP-114V intended for overactive bladder patients

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2017

At a glance

  • Drugs Vibegron (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions; Registrational
  • Sponsors Kyorin Pharmaceutical
  • Most Recent Events

    • 06 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 28 Dec 2015 New trial record
    • 05 Nov 2015 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top